Rolf Hultcrantz

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Mattias Ekstedt, Hannes Hagström, Patrik Nasr et al. · Hepatology · 2014 · 2.3K citations · Full text

Medicine, Internal Medicine, Pathology +17

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

Hannes Hagström, Patrik Nasr, Mattias Ekstedt et al. · Journal of Hepatology · 2017 · 1.1K citations

Medicine, Internal Medicine, Pathology +15

Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up

Cecilia Söderberg, Per Stål, Johan Askling et al. · Hepatology · 2009 · 756 citations · Full text

Medicine, Internal Medicine, Pathology +16

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

Annika Bergquist, Anders Ekbom, Rolf Olsson et al. · Journal of Hepatology · 2002 · 713 citations

Medicine, Internal Medicine, Pathology +14

Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis

Michael P. Manns, Marek Woynarowski, Wolfgang Kreisel et al. · Gastroenterology · 2010 · 443 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13